What is SNAP-8?
SNAP-8 is an acetylated octapeptide used in cosmetics. The featured study tested a combination patch with several active ingredients, so its result does not isolate the effect of SNAP-8.
Biological role or research focus
Combination topical-patch research.
This comparison cannot isolate SNAP-8, establish long-term effects, or validate every serum containing acetyl octapeptide-3.
Names you may encounter
Acetyl octapeptide-3 · SNAP 8
Search terms can include brands, combinations, or historical names. They are not automatic product equivalents.
- Class / identity
- Acetylated octapeptide cosmetic ingredient
- Research focus
- Combination topical-patch research
- Featured evidence
- Human comparative cosmetic study
- Source check
- October 4, 2026
Quick answers
- Is SNAP-8 FDA approved?
- No. No FDA-approved drug contains SNAP-8. Source ↗
- Is SNAP-8 safe?
- Cosmetic peptide, not a drug. One small short study of a combination patch reported no side effects, which cannot rule out skin reactions or long-term effects. Human safety data: very limited. The Risks & interactions section below lists what is known. Read the risks ↓
- Is SNAP-8 banned in sport?
- It is not named on the 2026 World Anti-Doping Agency (WADA) Prohibited List. Athletes should still check with their sport’s anti-doping body. Source ↗
What does the evidence show?
Evidence map
Every study featured on this page, grouped by what was actually tested. Human studies count most; animal and cell results often do not carry over to people.
| Study | Type | Population / model |
|---|---|---|
| Combination hyaluronic-acid patch for eye wrinkles (2024) | Human comparative cosmetic study | 24 healthy volunteers. |
Selected published evidence, with the population, findings, and limits kept together. These original summaries draw on publication abstracts; they are not a systematic review.
Human comparative cosmetic study · 2024
Combination hyaluronic-acid patch for eye wrinkles
What did this publication test, and what did it find?
- Population / model
- 24 healthy volunteers.
- Study design
- 28-day comparison of opposite eye areas using an active dissolving hyaluronic-acid patch and a hyaluronic-acid placebo patch.
- Main finding
- Several wrinkle measurements favored the active combination patch. No adverse events were reported during the short follow-up.
- Limits & context
- This comparison cannot isolate SNAP-8, establish long-term effects, or validate every serum containing acetyl octapeptide-3.
Read the original paper for methods, adverse events, funding, and conflicts of interest. Publisher access may require a subscription.
Registered human trials
No study naming SNAP-8 as an intervention was found on ClinicalTrials.gov when we last checked (November 16, 2026). That means no registered human trial, not proof that none has ever been done elsewhere.
Further reading · 0 additional publication links
Exact-name PubMed search checked 2026-10-04. These records have not been appraised. A name match can include related compounds, combinations, or other formulations; it does not establish safety or benefit.
No additional records were returned by this limited exact-name search. That is not evidence that no research exists; alternative scientific names may need investigation.
Repeat this PubMed search ↗Risks & interactions
Cosmetic peptide, not a drug. One small short study of a combination patch reported no side effects, which cannot rule out skin reactions or long-term effects.
One 28-day study of 24 volunteers used a multi-ingredient patch, so effects of SNAP-8 alone cannot be isolated. No adverse effects were reported. Other uses and long-term exposure have not been studied.
Unassessed: little human safety data
It isn't approved, so there is no official list of who should avoid it, and its human studies are too small to show who is most at risk. No condition is tagged, but that does not make it safe for anyone. If a condition applies to you, talk to a doctor or pharmacist first.
Who should not use it
There is no official list, because it has never been approved as a medicine. That is not a sign it is safe for anyone: its risks have not been studied enough to know who is most at risk.
Summarized from published studies with AI assistance; not reviewed by a clinician. Not a complete list, and not medical advice: talk to a doctor or pharmacist about your own situation. Checked 2026-10-10. Sources: Clinical safety of a dual anti-wrinkle microneedle patch (2024) ↗
Safety & what remains unknown
A small short cosmetic study cannot exclude uncommon skin reactions, and finished-product ingredients can differ.
Evidence boundaries
This comparison cannot isolate SNAP-8, establish long-term effects, or validate every serum containing acetyl octapeptide-3.
Regulatory status
- U.S. FDA approval
- Not approved
No FDA-approved drug containing this substance found in Drugs@FDA (openFDA data updated 2026-10-07). source - FDA compounding (503A bulk list)
- Not on FDA’s compounding lists
Not found on FDA's 503A category 1, 2 or 3 lists (updated May 14, 2026) or the category 2 safety-risk page (updated April 22, 2026). source - World Anti-Doping Agency (2026)
- Not on the WADA Prohibited List
Not named. It is a cosmetic ingredient; WADA's S0 catch-all addresses pharmacological substances, and its application to topical cosmetic ingredients was not determined. source
Checked October 28, 2026. Rules change; follow the source links for the current status. Regulatory tracker.
This is not a complete list of contraindications, interactions, or adverse effects. Medicine labels apply to specific products and indications; research-use listings are not interchangeable with approved medicines.
Research context & identity
The tested patch contained acetyl octapeptide-3, an ascorbic-acid derivative, and cyclic lysophosphatidic acid. The result should stay linked to that combination and delivery format.
New editorial updates
New source discoveries
Links appear automatically. Unreviewed discoveries are not verified medical findings.
Sources & supplier listings
Seller lab-report checks and prices are available to members. Sign up free
Biology & proposed mechanism
The publication compared finished patch formulations. Ingredient-level explanations are different from proof of the contribution of each ingredient.
Questions worth asking
- Did the study measure SNAP-8 as the only active ingredient?
- What material, population, and route were actually studied?
- This comparison cannot isolate SNAP-8, establish long-term effects, or validate every serum containing acetyl octapeptide-3.
- What adverse effects, uncertainty, and conflicts of interest does the original source report?
Frequently asked questions
Did the study measure SNAP-8 as the only active ingredient?
No. It tested a multi-ingredient patch, so the result cannot be assigned to SNAP-8 alone.
Does the publication verify a supplier’s product?
No. The tested material and a commercial listing need separate identity and batch checks. A research-use disclaimer does not establish clinical suitability.
References & editorial record
Source notes checked 2026-10-04. Original PepsRadar summaries. Not reviewed by a medical professional. Topic grouping is editorial navigation, not a treatment recommendation.
